 benefici effect colestipol-niacin coronari atherosclerosi follow-up cholesterol lower atherosclerosi studi cla random placebo-control angiograph trial colestipol-niacin therapi subject two-year result clas-i decreas atherosclerosi progress increas regress subgroup subject year clas-ii chang blood lipid lipoprotein-cholesterol apolipoprotein level year drug-treat subject nonprogress drug- vs placebo-tr regress drug- vs placebo-tr nativ coronari arteri lesion drug-treat subject new lesion nativ coronari arteri drug- vs placebo-tr bypass graft drug- vs placebo-tr result clas-i find regress year need earli initi vigor long-term lipid therapi coronari bypass subject